A phase I trial of LY2510924, a CXCR4 peptide antagonist, in patients with advanced cancer (Clinical Cancer Research (2014) 20, (3581-3588))

M. D. Galsky; N. J. Vogelzang; P. Conkling; E. Raddad; J. Polzer; S. Roberson

doi:10.1158/1078-0432.CCR-14-1611

A phase I trial of LY2510924, a CXCR4 peptide antagonist, in patients with advanced cancer (Clinical Cancer Research (2014) 20, (3581-3588))

M. D. Galsky, N. J. Vogelzang, P. Conkling, E. Raddad, J. Polzer, S. Roberson

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	4414
Number of pages	1
Journal	Clinical Cancer Research
Volume	20
Issue number	16
DOIs	https://doi.org/10.1158/1078-0432.CCR-14-1611
State	Published - 15 Aug 2014

Access to Document

10.1158/1078-0432.CCR-14-1611

Cite this

@article{ab165a799a604ced8ad05aa33d96d451,

title = "A phase I trial of LY2510924, a CXCR4 peptide antagonist, in patients with advanced cancer (Clinical Cancer Research (2014) 20, (3581-3588))",

author = "Galsky, {M. D.} and Vogelzang, {N. J.} and P. Conkling and E. Raddad and J. Polzer and S. Roberson",

year = "2014",

month = aug,

day = "15",

doi = "10.1158/1078-0432.CCR-14-1611",

language = "English",

volume = "20",

pages = "4414",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "16",

}

TY - JOUR

T1 - A phase I trial of LY2510924, a CXCR4 peptide antagonist, in patients with advanced cancer (Clinical Cancer Research (2014) 20, (3581-3588))

AU - Galsky, M. D.

AU - Vogelzang, N. J.

AU - Conkling, P.

AU - Raddad, E.

AU - Polzer, J.

AU - Roberson, S.

PY - 2014/8/15

Y1 - 2014/8/15

UR - http://www.scopus.com/inward/record.url?scp=84905962555&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-14-1611

DO - 10.1158/1078-0432.CCR-14-1611

M3 - Comment/debate

AN - SCOPUS:84905962555

SN - 1078-0432

VL - 20

SP - 4414

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 16

ER -